VPTDF (VentriPoint Diagnostics) Total Assets: $0.34 Mil (As of Dec. 2025)


VPTDF VentriPoint Diagnostics Ltd VPTDF
8 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics Total Assets?

VentriPoint Diagnostics VPTDF 8 Total Assets is $0.34 Mil as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Total Assets for the quarter that ended in Dec. 2025 was $0.34 Mil.

During the past 12 months, VentriPoint Diagnostics's average Total Assets Growth Rate was -30.20% per year. During the past 3 years, the average Total Assets Growth Rate was -19.20% per year. During the past 5 years, the average Total Assets Growth Rate was 12.40% per year. During the past 10 years, the average Total Assets Growth Rate was 6.90% per year.

During the past 13 years, VentriPoint Diagnostics's highest 3-Year average Total Assets Growth Rate was 302.50%. The lowest was -48.70%. And the median was 8.35%.

Total Assets is connected with ROA %. VentriPoint Diagnostics's annualized ROA % for the quarter that ended in Dec. 2025 was -188.62%. Total Assets is also linked to Revenue through Asset Turnover. VentriPoint Diagnostics's Asset Turnover for the quarter that ended in Dec. 2025 was 0.01.

VentriPoint Diagnostics  (OTCPK:VPTDF) Total Assets Explanation

Total Assets is connected with ROA %.

VentriPoint Diagnostics's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-0.58/( (0.273+0.342)/ 2 )
=-0.58/0.3075
=-188.62 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

VentriPoint Diagnostics's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.003/( (0.273+0.342)/ 2 )
=0.003/0.3075
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

VentriPoint Diagnostics Total Assets Related Terms

VentriPoint Diagnostics Total Assets Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Total Assets Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.46 4.40 1.40 0.46 0.34

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.62 0.39 0.27 0.34
VPTDF
8GF Score
VentriPoint Diagnostics Ltd VPTDF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

VentriPoint Diagnostics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-2.984+3.327
=0.34

VentriPoint Diagnostics's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-2.984+3.327
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.34 Mil mean?
VentriPoint Diagnostics (VPTDF) has a Total Assets of $0.34 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on VentriPoint Diagnostics and its competitors.
Is VentriPoint Diagnostics' Total Assets too high?
VentriPoint Diagnostics' current Total Assets is $0.34 Mil. Overall, VentriPoint Diagnostics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Total Assets compare to ABT and SYK?
VentriPoint Diagnostics' Total Assets of $0.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Total Assets is $0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Total Assets of $0.34 Mil. The current Total Assets is $0.34 Mil. VentriPoint Diagnostics' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Total Assets is $0.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
8GF Score

Get the complete analysis for VPTDF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price